personalized, responsive service and to improve the site, we remember and store information about how you use
The Translational Scientist
This month, we’re delving into the mysterious realm of long noncoding RNAs (lncRNAs), as research sheds new light on their functional significance in cancer. We also explore the potential for cell therapies to help patients with diabetes, and find out how a young entrepreneur is developing a potentially life-saving new treatment for malaria. We hear from the AllTrials campaign and GlaxoSmithKline Chief Medical Officer Murray Stewart on their plans to for greater clinical trial transparency. Plus, we sit down with regenerative medicine pioneer Anthony Atala, to discuss his biomaterial breakthroughs.